
Telum Therapeutics
@telum_tx
Biotech company focused on R&D of new antimicrobial compounds using innovative technology such as proteins (biologics) through our internal platform, APEXp.
ID: 1280899467210874880
http://telumtherapeutics.com 08-07-2020 16:20:13
93 Tweet
95 Followers
52 Following





#NuevoSocioAseBio🤝 | ¡Bienvenidos a nuestra #FamiliaBiotech, Telum Therapeutics ! Roberto Díez PhD, CEO & Co-fundador: “Asebio facilita la connexión de las start-ups innovadoras con la industria y los inversores” Lee la entrevista completa: asebio.com/actualidad/not… #SomosBiotecnología

We are new member of the Spanish Bioindustry Association (AseBio - Asociación Española de Bioempresas)! ow.ly/xYzx50OBCAW An excellent opportunity to connect Telum Therapeutics with the ecosystem. #WeAreBiotech #MachineLearning #DrugDiscovery #AntibioticResistance #AntimicrobialResistance



"No será posible tratar enfermedades infecciosas provocadas por #BacteriasMultirresistentes sin herramientas como la biología sintética y la inteligencia artificial" Roberto Díez-Martínez, CEO Telum Therapeutics, ya se ha sumado a #VidaALaBiotecnología 🤝¡Únete!: vidaalabiotecnologia.com





🎥 Searching for therapies to fight the most dangerous bacteria. A global public-health issue explained in Teknopolis, featuring Telum Therapeutics: buff.ly/3OdE9UD We are developing innovative therapies for #AntimicrobialResistance 🦠 on World Health Organization (WHO) top-priority list.




Telum Therapeutics joins the United Nations UN Global Compact, the world's largest corporate #sustainability initiative ♻️💚: bit.ly/4akPyv4 #ODS #AntimicrobialResistance #InfectiousDiseases #MachineLearning #DrugDiscovery #healthcare


🔬🚀 Exciting news! Telum Therapeutics joins the BEAM Alliance to strengthen the fight against #AMR. Together, we drive innovation in antimicrobial therapies! #Biotech #PhageTherapy #InfectiousDiseases 🌍🔗telumtherapeutics.com/telum-therapeu…

Telum Therapeutics, in collaboration with Complutense and Instituto de Salud Carlos III (ISCIII), discover next-generation antimicrobials against vancomycin-resistant E. Faecium: bit.ly/3XD9uVA Under the competitive call Public-private partnership projects (CPP) Ministerio de Ciencia, Innovación y Universidades European Commission
